Zealand Pharma rescue pen books USD 0.6m revenue in Q1

Zealand Pharma, a biotech firm publicly listed in Denmark, has released its first quarterly report for 2022 on Thursday.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Zealand Pharma changes financing agreement
For subscribers